InsidersTradesSigma
Browse the detailed record of transactions filed by DECICCO CARL, Directeur Scientifique. Insider active across 1 companies, notably Foghorn Therapeutics Inc.. Cumulatively, 2 reports have been published. The latest transaction was disclosed on 9 December 2021 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
DECICCO CARL is the Chief Scientific Officer at Foghorn Therapeutics Inc. In this role, he oversees research and development initiatives, ensuring innovation and advancement of scientific projects. Carl brings expertise in the biotechnology field, contributing to the evolution of gene therapies.